Cochlear profit up
Tuesday, 12 August, 2008
In a difficult year, Cochlear [ASX: COH] has posted excellent year-end results, with net profit up 15 per cent from last year.
Total revenue was $601.7 million, up eight per cent, for a net profit after tax of $115.2 million, slightly below forecasts.
Sales revenue has grown 18 per cent, after accounting for the appreciation of the Australian dollar.
Shareholders will be rewarded with a dividend of 80 cents per share.
The company said it expected double-digit growth again next year.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
